New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections

Ken B Waites1, Mitchell F Balish, T Prescott Atkinson

  • 1University of Alabama at Birmingham, WP 230, 619 19th Street South, Birmingham, AL 35249, USA. waiteskb@uab.edu

Future Microbiology
|December 17, 2008
PubMed

Insights

Mycoplasma pneumoniae causes respiratory infections and extrapulmonary events. This review covers its pathology, host immune interactions, asthma links, macrolide resistance, and diagnostics.

Area of Science:

  • Medical Microbiology
  • Immunology
  • Pulmonology

Background:

  • Mycoplasma pneumoniae is a frequent cause of community-acquired pneumonia (CAP) and other respiratory tract infections.
  • Infections can lead to diverse extrapulmonary manifestations due to autoimmunity or direct pathogen spread.
  • Understanding these aspects is crucial for managing patient health and disease progression.

Purpose of the Study:

  • To review current knowledge on the molecular pathology of Mycoplasma pneumoniae respiratory infections.
  • To explore the organism's interaction with the host immune system.
  • To discuss its association with chronic conditions, antimicrobial resistance, and diagnostic advancements.

Main Methods:

  • Literature review of recent research on Mycoplasma pneumoniae.
  • Analysis of molecular mechanisms in pathogenesis.
  • Examination of epidemiological data on resistance and diagnostics.

Main Results:

  • Mycoplasma pneumoniae exhibits complex molecular pathological mechanisms.
  • Host immune responses play a significant role in disease development and extrapulmonary events.
  • Emerging macrolide resistance and evolving diagnostic techniques are critical considerations.

Conclusions:

  • Mycoplasma pneumoniae infections require comprehensive understanding of pathogenesis and host response.
  • The link to chronic conditions like asthma warrants further investigation.
  • Monitoring resistance and improving diagnostics are essential for effective treatment strategies.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...